Triplet therapy with androgen deprivation, docetaxel, and androgen receptor signalling inhibitors in metastatic castration-sensitive prostate cancer: A meta-analysis
Chiara Ciccarese, Roberto Iacovelli, Cora N. Sternberg, Silke Gillessen, Giampaolo Tortora, Karim Fizazi
Topics & Concepts
DocetaxelMedicineProstate cancerOncologyAndrogen deprivation therapyInternal medicineHazard ratioRegimenSubgroup analysisClinical trialMeta-analysisCancerConfidence intervalProstate Cancer Treatment and ResearchProstate Cancer Diagnosis and TreatmentBone health and treatments